{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:27:12Z","timestamp":1769030832882,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["DIR\/Wk\/2018\/06"],"award-info":[{"award-number":["DIR\/Wk\/2018\/06"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2022\/45\/N\/ST4\/02628"],"award-info":[{"award-number":["2022\/45\/N\/ST4\/02628"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["NI 643\/11-1"],"award-info":[{"award-number":["NI 643\/11-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bioorg.2025.109446","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:33:30Z","timestamp":1766734410000},"page":"109446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel fluoro-brominated benzotriazoles as potential CK2 inhibitors. How does fluorination affect the properties of benzotriazoles?"],"prefix":"10.1016","volume":"169","author":[{"given":"S\u0142awomir","family":"Kasperowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Podsiad\u0142a-Bia\u0142osk\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Szo\u0142ajska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka M.","family":"Maciejewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Lindenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Niefind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Pozna\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Winiewska-Szajewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109446_bb0005","article-title":"Computer-based simulators in pharmacy practice education: a systematic narrative review","volume":"11","author":"Gharib","year":"2023","journal-title":"Pharmacy"},{"key":"10.1016\/j.bioorg.2025.109446_bb0010","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0021-9258(18)71184-8","article-title":"The enzymatic phosphorylation of proteins","volume":"211","author":"Burnett","year":"1954","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N","article-title":"Protein kinase CK2 and its role in cellular proliferation, development and pathology","volume":"20","author":"Guerra","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bioorg.2025.109446_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021469","article-title":"Protein kinase CK2: structure, regulation and role in cellular decisions of life and death","volume":"369","author":"Litchfield","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2025.109446_bb0025","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.1074\/jbc.275.19.14295","article-title":"Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2","volume":"275","author":"Bosc","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells12242834","article-title":"Protein kinase CK2\u03b1\u2019, more than a backup of CK2\u03b1","volume":"12","author":"Montenarh","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2025.109446_bb0035","first-page":"207A","article-title":"A novel casein kinase 2 alpha subunit regulates membrane protein traffic in the human hepatoma cell line HuH-7","volume":"11","author":"Stockert","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bioorg.2025.109446_bb0040","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/B978-0-12-381298-8.00023-X","article-title":"Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: Strategies to identify CK2 substrates and manipulate its activity in mammalian cells","volume":"484","author":"Turowec","year":"2010"},{"key":"10.1016\/j.bioorg.2025.109446_bb0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbapap.2009.07.018","article-title":"Addiction to protein kinase CK2: a common denominator of diverse cancer cells?","volume":"1804","author":"Ruzzene","year":"2010","journal-title":"Biochimica Et Biophysica Acta-Proteins Proteomics"},{"key":"10.1016\/j.bioorg.2025.109446_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0163-7258(98)00064-3","article-title":"CK2: a protein kinase in need of control","volume":"82","author":"Guerra","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.109446_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2015.10.021","article-title":"Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes","volume":"103","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.109446_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.drudis.2015.07.008","article-title":"Small-molecule kinase inhibitors: an analysis of FDA-approved drugs","volume":"21","author":"Wu","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109446_bb0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109446_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/092986713804999312","article-title":"Kinase CK2 inhibition: an update","volume":"20","author":"Cozza","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/BJ20070825","article-title":"Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction","volume":"408","author":"Laudet","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2025.109446_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41598-019-52141-5","article-title":"Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors","volume":"9","author":"Kufareva","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109446_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.seminoncol.2018.04.006","article-title":"CIGB-300: a peptide-based drug that impairs the protein kinase CK2-mediated phosphorylation","volume":"45","author":"Perea","year":"2018","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109446_bb0090","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1039\/c2ob26022k","article-title":"A subnanomolar fluorescent probe for protein kinase CK2 interaction studies","volume":"10","author":"Enkvist","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47404-0","article-title":"Rational drug-design approach supported with thermodynamic studies - a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2","volume":"9","author":"Winiewska-Szajewska","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109446_bb0100","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1021\/bi2008382","article-title":"Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer","volume":"50","author":"Battistutta","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2025.109446_bb0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/jm101251q","article-title":"Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of Cancer","volume":"54","author":"Pierre","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109446_bb0115","volume":"39","year":"2017","journal-title":"Oncology Times"},{"key":"10.1016\/j.bioorg.2025.109446_bb0120","doi-asserted-by":"crossref","first-page":"20702","DOI":"10.1021\/acsomega.3c10478","article-title":"Recent advances in the discovery of CK2 inhibitors","volume":"9","author":"Al-Qadhi","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109446_bb0125","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits Prosurvival and angiogenic Signaling and exhibits antitumor efficacy","volume":"70","author":"Siddiqui-Jain","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109446_bb0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1021\/j100785a001","article-title":"Van der waals volumes + radii","volume":"68","author":"Bondi","year":"1964","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0135","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1021\/acs.jmedchem.9b01877","article-title":"Metabolic and pharmaceutical aspects of fluorinated compounds","volume":"63","author":"Johnson","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/ar020230d","article-title":"Bond dissociation energies of organic molecules","volume":"36","author":"Blanksby","year":"2003","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.109446_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.pharmtox.41.1.443","article-title":"Metabolism of fluorine-containing drugs","volume":"41","author":"Park","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2025.109446_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-1139(01)00375-X","article-title":"Fluorine substituent effects (on bioactivity)","volume":"109","author":"Smart","year":"2001","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cbic.200301023","article-title":"Fluorine in medicinal chemistry","volume":"5","author":"B\u00f6hm","year":"2004","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2025.109446_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202201601","article-title":"Impact of fluoroalkyl substituents on the physicochemical properties of saturated heterocyclic amines","volume":"28","author":"Melnykov","year":"2022","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2025.109446_bb0165","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1002\/chem.202002825","article-title":"Addressing the structural complexity of fluorinated glucose analogues: insight into lipophilicities and solvation effects","volume":"26","author":"St-Gelais","year":"2020","journal-title":"Chem.-A Eur. J."},{"key":"10.1016\/j.bioorg.2025.109446_bb0170","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1021\/acs.jmedchem.5b01455","article-title":"Fluorination patterning: a study of structural motifs that impact physicochemical properties of relevance to drug discovery","volume":"58","author":"Huchet","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0175","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.1073\/pnas.0915169107","article-title":"Molecular origins of fluorocarbon hydrophobicity","volume":"107","author":"Dalvi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109446_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfluchem.2024.110384","article-title":"Lipophilicity effects of monofluorination at the tertiary aliphatic carbon as a function of \u03b1-substituent","volume":"281","author":"Melnykov","year":"2025","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0185","series-title":"Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals","first-page":"91","article-title":"Fluorination patterns in small alkyl groups\u202f: their impact on properties relevant to drug discovery","author":"Muller","year":"2019"},{"key":"10.1016\/j.bioorg.2025.109446_bb0190","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1016\/S0968-0896(03)00403-6","article-title":"Polyhalogenobenzimidazoles: synthesis and their inhibitory activity against casein kinases","volume":"11","author":"Andrzejewska","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0195","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bmc.2008.12.071","article-title":"Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide-potential inhibitors of human protein kinase CK2","volume":"17","author":"Najda-Bernatowicz","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0200","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbapap.2005.07.043","article-title":"Features and potentials of ATP-site directed CK2 inhibitors","volume":"1754","author":"Sarno","year":"2005","journal-title":"Biochimica Et Biophysica Acta-Proteins Proteomics"},{"key":"10.1016\/j.bioorg.2025.109446_bb0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41598-021-03136-8","article-title":"5,6-diiodo-1H-benzotriazole: new TBBt analogue that minutely affects mitochondrial activity","volume":"11","author":"Paprocki","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109446_bb0210","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bbrc.2004.07.067","article-title":"2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2","volume":"321","author":"Pagano","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.109446_bb0215","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1021\/jp301561x","article-title":"Synthesis and Physico-chemical properties in aqueous medium of all possible isomeric Brom analogues of benzo-1H-triazole, potential inhibitors of protein kinases","volume":"116","author":"Wasik","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2025.109446_bb0220","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/iub.2271","article-title":"A competition between hydrophobic and electrostatic interactions in protein-ligand systems. Binding of heterogeneously halogenated benzotriazoles by the catalytic subunit of human protein kinase CK2","volume":"72","author":"Kasperowicz","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bioorg.2025.109446_bb0225","doi-asserted-by":"crossref","first-page":"16789","DOI":"10.1073\/pnas.0407607101","article-title":"Halogen bonds in biological molecules","volume":"101","author":"Auffinger","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109446_bb0230","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2174\/156802607781696846","article-title":"The role of halogen bonding in inhibitor recognition and binding by protein kinases","volume":"7","author":"Voth","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0235","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja9086352","article-title":"Thermodynamics of halogen bonding in solution: substituent, structural, and solvent effects","volume":"132","author":"Sarwar","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109446_bb0240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00894-006-0130-2","article-title":"Halogen bonding: the sigma-hole","volume":"13","author":"Clark","year":"2007","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.bioorg.2025.109446_bb0245","series-title":"Halogen Bonding I: Impact on Materials Chemistry and Life Sciences","first-page":"241","article-title":"Biomolecular halogen bonds","author":"Ho","year":"2015"},{"key":"10.1016\/j.bioorg.2025.109446_bb0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.18388\/abp.2015_1106","article-title":"Halogen bonds involved in binding of halogenated ligands by protein kinases","volume":"63","author":"Poznanski","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bioorg.2025.109446_bb0255","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1021\/acs.jpcb.0c10264","article-title":"Halogen atoms in the protein-ligand system. Structural and thermodynamic studies of the binding of Bromobenzotriazoles by the catalytic subunit of human protein kinase CK2","volume":"125","author":"Czapinska","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2025.109446_bb0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejmech.2014.07.019","article-title":"Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2 alpha and cytotoxicity properties","volume":"84","author":"Borowiecki","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0265","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.polymer.2014.02.046","article-title":"D-A copolymers based on 5,6-difluorobenzotriazole and oligothiophenes: synthesis, field effect transistors, and polymer solar cells","volume":"55","author":"Liu","year":"2014","journal-title":"Polymer"},{"key":"10.1016\/j.bioorg.2025.109446_bb0270","series-title":"Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof","author":"Soll","year":"2008"},{"key":"10.1016\/j.bioorg.2025.109446_bb0275","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1021\/jm00010a023","article-title":"Hypoxia-selective agents derived from quinoxaline 1,4-di-n-oxides","volume":"38","author":"Monge","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0280","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1021\/jp102848y","article-title":"Relative role of halogen bonds and hydrophobic interactions in inhibition of human protein kinase CK2 alpha by Tetrabromobenzotriazole and some C(5)-substituted analogues","volume":"114","author":"Wasik","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2025.109446_bb0285","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/jp071611h","article-title":"Experimental (C-13 NMR) and theoretical (ab initio molecular orbital calculations) studies on the prototropic tautomerism of benzotriazole and some derivatives symmetrically substituted on the benzene ring","volume":"111","author":"Poznanski","year":"2007","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.bioorg.2025.109446_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-51905-y","article-title":"Effect of histidine protonation state on ligand binding at the ATP-binding site of human protein kinase CK2","volume":"14","author":"Winiewska-Szajewska","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109446_bb0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ab.2004.04.031","article-title":"Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery","volume":"332","author":"Lo","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2011.01.020","article-title":"Structure of the human protein kinase CK2 catalytic subunit CK2\u03b1\u2019 and interaction thermodynamics with the regulatory subunit CK2\u03b2","volume":"407","author":"Bischoff","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.109446_bb0305","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1021\/acsomega.8b03415","article-title":"Diacritic binding of an Indenoindole inhibitor by CK2\u03b1 paralogs explored by a reliable path to atomic resolution CK2\u03b1\u2019 structures","volume":"4","author":"Lindenblatt","year":"2019","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109446_bb0310","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/kinasesphosphatases1040018","article-title":"Discovery and exploration of protein kinase CK2 binding sites using CK2\u03b1\u2019 Cys336Ser as an exquisite crystallographic tool","volume":"1","author":"Werner","year":"2023","journal-title":"Kinases Phosphatases"},{"key":"10.1016\/j.bioorg.2025.109446_bb0315","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1039\/C6SC02335E","article-title":"Specific inhibition of CK2\u03b1 from an anchor outside the active site","volume":"7","author":"Brear","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.109446_bb0320","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bbapap.2015.04.004","article-title":"Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2 alpha","volume":"1854","author":"Winiewska","year":"2015","journal-title":"Biochimica Et Biophysica Acta-Proteins Proteomics"},{"key":"10.1016\/j.bioorg.2025.109446_bb0325","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1021\/acs.joc.9b02198","article-title":"Selective synthesis of N-H and N-aryl benzotriazoles by the 3+2 annulation of sodium Azide with arynes","volume":"84","author":"Guin","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0330","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1039\/C9OB00615J","article-title":"Making endo-cyclizations favorable again: a conceptually new synthetic approach to benzotriazoles via azide group directed lithiation\/cyclization of 2-azidoaryl bromides","volume":"17","author":"Ageshina","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109446_bb0335","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/iub.2257","article-title":"Thermodynamic contribution of iodine atom to the binding of heterogeneously polyhalogenated benzotriazoles by the catalytic subunit of human protein kinase CK2","volume":"72","author":"Marzec","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bioorg.2025.109446_bb0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1371\/journal.pone.0173260","article-title":"ITC-derived binding affinity may be biased due to titrant (nano)-aggregation. Binding of halogenated benzotriazoles to the catalytic domain of human protein kinase CK2","volume":"12","author":"Winiewska","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.109446_bb0345","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11095-007-9517-8","article-title":"A novel design of artificial membrane for improving the PAMPA model","volume":"25","author":"Chen","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioorg.2025.109446_bb0350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1107\/S0909049506004341","article-title":"The ID23-1 structural biology beamline at the ESRF","volume":"13","author":"Nurizzo","year":"2006","journal-title":"J. Synchrotron Radiat."},{"key":"10.1016\/j.bioorg.2025.109446_bb0355","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1107\/S1600577520004002","article-title":"ID30A-3 (MASSIF-3) - a beamline for macromolecular crystallography at the ESRF with a small intense beam","volume":"27","author":"von Stetten","year":"2020","journal-title":"J. Synchrotron Radiat."},{"key":"10.1016\/j.bioorg.2025.109446_bb0360","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and analysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallographica Section D-Struct. Biol."},{"key":"10.1016\/j.bioorg.2025.109446_bb0365","series-title":"XDS. Acta Crystallographica Section D-Biological Crystallography","first-page":"125","volume":"66","author":"Kabsch","year":"2010"},{"key":"10.1016\/j.bioorg.2025.109446_bb0370","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallographica Section D-Biological Crystallography"},{"key":"10.1016\/j.bioorg.2025.109446_bb0375","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallographica Section D-Structural Biology"},{"key":"10.1016\/j.bioorg.2025.109446_bb0380","series-title":"STARANISO","author":"Tickle","year":"2018"},{"key":"10.1016\/j.bioorg.2025.109446_bb0385","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"Mccoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2025.109446_bb0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallographica Section D-Structural Biology"},{"key":"10.1016\/j.bioorg.2025.109446_bb0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1107\/S090744490705024X","article-title":"Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard","volume":"64","author":"Terwilliger","year":"2008","journal-title":"Acta Crystallographica Section D-Biological Crystallography"},{"key":"10.1016\/j.bioorg.2025.109446_bb0400","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.Refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallographica Section D-Structural Biology"},{"key":"10.1016\/j.bioorg.2025.109446_bb0405","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallographica Section D-Structural Biology"},{"key":"10.1016\/j.bioorg.2025.109446_bb0410","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallographica Section D-Structural Biology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825013264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825013264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:04:52Z","timestamp":1768975492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825013264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":82,"alternative-id":["S0045206825013264"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109446","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel fluoro-brominated benzotriazoles as potential CK2 inhibitors. How does fluorination affect the properties of benzotriazoles?","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109446"}}